Fianlimab, LIBTAYO 350 mg concentrate for solution for infusion., Placebo for Fianlimab
R3767-ONC-2235
Phase 3 small_molecule active
Quick answer
Fianlimab, LIBTAYO 350 mg concentrate for solution for infusion., Placebo for Fianlimab for Advanced Non-Small Cell Lung Cancer is a Phase 3 program (small_molecule) at Pharma Mar S.A. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pharma Mar S.A.
- Indication
- Advanced Non-Small Cell Lung Cancer
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active